Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2020; 10(Volume 10, Issue 4.000): 14-21


Prednisolone encapsulated PLGA nanoparticles: Characterization, cytotoxicity and anti-inflammatory activity on C6 glial cells

Sriprasad Acharya, Bharath Raja Guru.




Abstract
Cited by 8 Articles

Prednisolone, a popular glucocorticoid known for its ability to inhibit cytokine release is also employed extensively in cancer therapy. Glucocorticoids have been used to treat brain tumors to reduce tumor associated edema. They are known to exhibit different effects on different cell lines and in some cases are known to be neurotoxic. In this study we have investigated and compared the cytotoxic and anti-inflammatory effects of prednisolone and prednisolone encapsulated Poly Lactic-co-Glycolic acid (PLGA) nanoparticles (NP’s) on C6 cells that are cancerous but are known for their similarity to astrocyte cells. Design expert software was used to analyze the effect of different variables for nanoparticle formulation. By varying different parameters nanoparticles were synthesized and characterized using particle size analyzer, zeta potential. Surface morphology of the NP’s were analyzed using scanning electron microscopy (SEM). Lipopolysaccharide (LPS) activated C6 glial cells witnessed significantly lower cell proliferation in the presence of the drug during the 48 h incubation and the prednisolone encapsulated NP’s were able to attenuate pro-inflammatory cytokines like TNF-α and Nitric oxide (NO) substantially even after the 72 h of incubation when compared it with free drug. The results suggested that prednisolone was more effective as an anti-inflammatory drug in the PLGA nanoformulation.

Key words: Prednisolone nanoparticles, anti-inflammatory, cytotoxicity, Factorial design






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.